DOI QR코드

DOI QR Code

간세포암으로 오인된 직장에 발생한 간양 선암종의 간전이 CT 소견: 증례 보고

CT Findings of Hepatic Metastasis from Hepatoid Adenocarcinoma of the Rectum Mimicking Hepatocellular Carcinoma: A Case Report

  • Tae Hoon Lim (Department of Radiology, Yeungnam University Hospital) ;
  • Jae Woon Kim (Department of Radiology, Yeungnam University Hospital) ;
  • Min Jong Kim (Department of Pathology, Yeungnam University Hospital)
  • 투고 : 2023.02.15
  • 심사 : 2023.08.08
  • 발행 : 2024.03.01

초록

간양 선암종은 선암종의 드문 유형 중 하나로 면역표현형에 있어 간세포암과 유사한 조직 소견이 있는 경우 진단할 수 있다. 임상적으로 혈청 알파태아단백질의 증가와 조기 간 전이로 인한 나쁜 예후를 보인다. 특히 간 전이의 경우 간세포암과 영상의학적 소견이 비슷하여 감별에 어려움을 겪는다. 여러 장기에서 발생할 수 있으나 위에서 가장 많이 기원하며 직장에서 기원하는 경우는 매우 드문 것으로 알려져 있다. 본 증례에서는 64세 여자 환자가 간에 발생한 수 개의 종양을 주소로 내원했다. 검사과정에서 직장암을 발견하였으며 이후 조직검사를 통해 간양 선암종으로 진단하였다. 이에 저자들은 문헌고찰과 함께 보고하는 바이다.

Hepatoid adenocarcinoma (HAC) is a rare form of adenocarcinoma that is diagnosed based on immuno-histochemical findings reminiscent of hepatocellular carcinoma (HCC). The clinical characteristics of HAC include increased levels of serum alpha-fetoprotein and a poor prognosis due to early liver metastasis. In particular, diagnosing liver metastasis of HAC can be challenging owing to radiological findings similar to those of HCC. Although HAC can occur in various organs, the stomach is the most common site. We present the case of a 64-year-old femalewho presented with multiple tumors in the liver. During subsequent examination, rectal cancer was identified and diagnosed as HAC through a biopsy. Herein, we report this case along with a literature review.

키워드

참고문헌

  1. Wang W, Li G. Incidence and prognostic factors of hepatoid adenocarcinoma: a population-based analysis. Transl Cancer Res 2020;9:5401-5410 https://doi.org/10.21037/tcr-20-1126
  2. Chandan VS, Shah SS, Torbenson MS, Wu TT. Arginase-1 is frequently positive in hepatoid adenocarcinomas. Hum Pathol 2016;55:11-16 https://doi.org/10.1016/j.humpath.2016.04.008
  3. Adachi Y, Tsuchihashi J, Shiraishi N, Yasuda K, Etoh T, Kitano S. AFP-producing gastric carcinoma: multivariate analysis of prognostic factors in 270 patients. Oncology 2003;65:95-101 https://doi.org/10.1159/000072332
  4. Jourreille J, Metayer P, Sauger F, Matray F, Fondimare A. Existence of alpha feto protein during gastric-origin secondary cancer of the liver. Presse Med 1970;78:1277-1278
  5. Metzgeroth G, Strobel P, Baumbusch T, Reiter A, Hastka J. Hepatoid adenocarcinoma - review of the literature illustrated by a rare case originating in the peritoneal cavity. Onkologie 2010;33:263-269 https://doi.org/10.1159/000305717
  6. Chen Y, Schaeffer DF, Yoshida EM. Hepatoid adenocarcinoma of the colon in a patient with inflammatory bowel disease. World J Gastroenterol 2014;20:12657-12661 https://doi.org/10.3748/wjg.v20.i35.12657
  7. Su JS, Chen YT, Wang RC, Wu CY, Lee SW, Lee TY. Clinicopathological characteristics in the differential diagnosis of hepatoid adenocarcinoma: a literature review. World J Gastroenterol 2013;19:321-327 https://doi.org/10.3748/wjg.v19.i3.321
  8. Qu BG, Bi WM, Qu BT, Qu T, Han XH, Wang H, et al. PRISMA-compliant article: clinical characteristics and factors influencing prognosis of patients with hepatoid adenocarcinoma of the stomach in China. Medicine (Baltimore) 2016;95:e3399
  9. Thian YL, Low AS, Chow PK, Ooi LL, Chung AY, Low SC, et al. Atypical enhancement pattern of hepatocellular carcinoma with portal vein thrombosis on multiphasic CT. Ann Acad Med Singap 2011;40:454-459 https://doi.org/10.47102/annals-acadmedsg.V40N10p454
  10. Araki T, Suda K, Sekikawa T, Ishii Y, Hihara T, Kachi K. Portal venous tumor thrombosis associated with gastric adenocarcinoma. Radiology 1990;174(3 Pt 1):811-814 https://doi.org/10.1148/radiology.174.3.1689502